新闻中心ABOUT
公司简介
公司简介
More
Avidity于1996年成立,由Millard Cull,Larry Lansing,Ron Gill博士和Mark Seville博士共同创立....
AviTag技术
AviTag技术
More
AviTag是Peter Schatz博士在Affymax公司发现的一种专利生物素标记技术....
企业未来
企业未来
More
随着Avidity的成熟,该公司正在扩大其科学视野,并研究生物发光的用途(例如深海生物中发现的这种用途)....
快速订货
快速订货
More
联系上海起发实验试剂有限公司进行快速订购,邮箱fige007@163.com或访问我们中国代理商的官方网站www.qfbio.com进行查询....
技术研究技术研究技术研究TECHNICAL
Biotinylated Recombinant Proteins
Biotinylated Recombinant Proteins
2021-06-14
Gaussia princeps Luciferase Biotinylated Avitag fusion (Cterminus) Gaussia princeps luciferase is a bioluminescent protein. It is ATP-independent, requiring only coelenterazine and O2 as substrates. This purified protein is fused with Avita...
Vectors
Vectors
2021-06-14
Avidty teamed with Atum (formerly DNA 2.0) to offer our customers an easy solution to AviTagging their E. coli expressed proteins. The new vectors employ the Atum ElectraTm system for easy cloning from a PCR product. To minimize steric conf...
In vivo Biotinylation-Strains
In vivo Biotinylation-Strains
2021-06-14
STRAIN AVB101 Strain AVB101, an E. coli B strain (hsdR, lon11, sulA1), contains pBirAcm , an IPTG inducible plasmid containing the BirA gene engineered into pACYC184. It is compatible with most cloning vectors and is maintained with chloram...
In vitro Biotinylation of Avitag with Enzyme
In vitro Biotinylation of Avitag with Enzyme
2021-06-14
BIOTIN PROTIEN LIGASE Biotin-protein ligase (EC 6.3.4.15) activates biotin to form biotinyl 5 adenylate and transfers the biotin to biotin-accepting proteins. It also functions as a biotin operon repressor. This protein is encoded by the bi...
Monoclonal antibody against C-terminus presented Av
Monoclonal antibody against C-terminus presented Av
2021-06-14
A monoclonal antibody was developed that reacts only to the AviTag when fused to the C-terminus of desired protein. It will identify C-terminus fusions on western blots and has been immobilized on agarose beads for purifications purposes. T...
服务中心RESOURCE

TEL:    QQ:    

Copyright © 2004-2011 DEDECMS. 织梦科技 版权所有

网站总访问量: